Recommended Talks:

Cent Gardes Conference: HIV Vaccines
Characterizing antibodies from new populations
October 2015
Julie Overbaugh, Fred Hutchinson Cancer Research Center, United States
Cent Gardes Conference: HIV Vaccines
Ability to Develop Broadly Neutralizing HIV-1 Antibodies is not Restricted by the Germline Immunoglobulin Gene Repertoire
October 2015
Lynn Morris, National Institute for Communicable Diseases, South Africa
Product Development Boot Camp
Principles of portfolio management in industry
November 2015
Jerry Sadoff, Janssen Pharmaceutical Companies
Innovative Uses of Technology in HIV Clinical Trials
Overview of IAVI Fingerprint projects, and use of fingerprinting in fishing communities in Uganda
April 2016
Anatoli Kamali, Medical Research Council Uganda and IAVI
Development of SHIVs for Vaccine Evaluation in NHP
June 2016
Introduction
Yegor Voronin, Global HIV Vaccine Enterprise
Workshop Overview
Alan Schultz, Division of AIDS, NIAID
Transmitted/Founder SHIVs
Theodora Hatziioannou, The Aaron Diamond AIDS Research Center
“Designer” SHIVs for HIV Vaccine and Cure Research
George M. Shaw, University of Pennsylvania
Discussion

Search:

Search term(s):

Search for text in:

separate each search
term with a space

Multiple terms:

Conference Years:

Content Type:

Latest Additions

Meeting Format: 1 day meeting   |   July 2016
Review the neut-sensitivity of Tiered virus panels and discuss the appropriate use of Tier-1A, -1B and -2 viruses for future vaccine development efforts. Webcasts | Learn More
Meeting Format: 1 day meeting   |   June 2016
Investigators generating and characterizing new SHIVs and clinical researchers using such challenge viruses convened to advance current research efforts. Webcasts
Meeting Format: 1 day meeting   |   April 2016
Various stakeholders share past experiences of innovative uses of technologies and discuss what could be adopted in future HIV clinical trials. Webcasts | Learn More
Meeting Format: 2 day meeting   |   November 2015
Presentations by product development experts, introduction to new resources, and active learning through discussion with peers and experts. Webcasts | Learn More
Meeting Format: 3 day meeting   |   October 2015
A webcast featuring several of the presentations of the 2015 Cent Gardes meeting, addressing a range of topics pertinent to HIV vaccine research. Webcasts | Learn More
Meeting Format: 1 hour webinar   |   September 2015
Immunologists and HIV vaccine experts review recent developments in germinal center (GC) biology and evaluate implications of defective GC physiology. Webcasts | Learn More
Meeting Format: 2 hour meeting   |   July 2015
An interactive session at IAS 2015 to explore the rapidly evolving HIV vaccine field, ranging from vaccine design to development and testing. Webcasts | Learn More
Meeting Format: 2 day meeting   |   June 2015
An exchange of information and experiences and a status update of ongoing efforts related to the GMP manufacturing of HIV ENV proteins. Webcasts | Learn More
Meeting Format: 2 hour webinar   |   May 2015
A focus on immunogens design, novel immunization regimens, and tracking of antibody responses with the goal of eliciting broadly neutralizing antibodies. Webcasts | Learn More
Meeting Format: 1 day meeting   |   May 2015
Review the landscape of past, current and future nucleic acid delivery technologies and learn from the experience of representative clinical trials. Webcasts | Learn More
1 2